PDB Short entry for 1JS3 HEADER LYASE 16-AUG-01 1JS3 TITLE CRYSTAL STRUCTURE OF DOPA DECARBOXYLASE IN COMPLEX WITH THE INHIBITOR TITLE 2 CARBIDOPA COMPND MOL_ID: 1; COMPND 2 MOLECULE: DOPA DECARBOXYLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AROMATIC-L-AMINO-ACID DECARBOXYLASE; DDC; COMPND 5 EC: 4.1.1.28; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 ORGAN: KIDNEY; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PKKDDC(DELTA)4 KEYWDS DOPA DECARBOXYLASE, CARBIDOPA, PARKINSON'S DISEASE, VITAMIN B6, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR P.BURKHARD,P.DOMINICI,C.BORRI-VOLTATTORNI,J.N.JANSONIUS, AUTHOR 2 V.N.MALASHKEVICH REVDAT 5 07-FEB-24 1JS3 1 REMARK HETSYN LINK REVDAT 4 13-JUL-11 1JS3 1 VERSN REVDAT 3 24-FEB-09 1JS3 1 VERSN REVDAT 2 30-SEP-03 1JS3 1 JRNL DBREF REVDAT 1 26-OCT-01 1JS3 0 JRNL AUTH P.BURKHARD,P.DOMINICI,C.BORRI-VOLTATTORNI,J.N.JANSONIUS, JRNL AUTH 2 V.N.MALASHKEVICH JRNL TITL STRUCTURAL INSIGHT INTO PARKINSON'S DISEASE TREATMENT FROM JRNL TITL 2 DRUG-INHIBITED DOPA DECARBOXYLASE. JRNL REF NAT.STRUCT.BIOL. V. 8 963 2001 JRNL REFN ISSN 1072-8368 JRNL PMID 11685243 JRNL DOI 10.1038/NSB1101-963 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.N.MALASHKEVICH,P.BURKHARD,P.DOMINICI,P.S.MOORE, REMARK 1 AUTH 2 C.BORRI-VOLTATTORNI,J.N.JANSONIUS REMARK 1 TITL PRELIMINARY X-RAY ANALYSIS OF A NEW CRYSTAL FORM OF PIG REMARK 1 TITL 2 KIDNEY DOPA DECARBOXYLASE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 55 568 1999 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444998006283 REMARK 1 REFERENCE 2 REMARK 1 AUTH V.N.MALASHKEVICH,P.FILIPPONI,U.SAUDER,P.DOMINICI, REMARK 1 AUTH 2 J.N.JANSONIUS,C.BORRI-VOLTATTORNI REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS OF PIG KIDNEY REMARK 1 TITL 2 DOPA DECARBOXYLASE REMARK 1 REF J.MOL.BIOL. V. 224 1167 1992 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2350530.700 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 53582 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.144 REMARK 3 FREE R VALUE : 0.187 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2722 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7404 REMARK 3 BIN R VALUE (WORKING SET) : 0.1800 REMARK 3 BIN FREE R VALUE : 0.2150 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 418 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7250 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 455 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.34000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : 0.67000 REMARK 3 B12 (A**2) : 2.14000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.970 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 30.50 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : PARAM REMARK 3 PARAMETER FILE 4 : PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JS3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1000014124. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-93 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : LURE REMARK 200 BEAMLINE : D41A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9500 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53582 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 19.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.19000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP, DM REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MME 5000, MES, AMMONIUM SULFATE AT REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP AT 298K, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.85333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.92667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 57.85333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.92667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE DIMER WHICH IS THE REMARK 300 BIOLOGICALLY ACTIVE OLIGOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -146.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 328 REMARK 465 ASP A 329 REMARK 465 PRO A 330 REMARK 465 VAL A 331 REMARK 465 TYR A 332 REMARK 465 LEU A 333 REMARK 465 LYS A 334 REMARK 465 HIS A 335 REMARK 465 SER A 336 REMARK 465 HIS A 337 REMARK 465 GLN A 338 REMARK 465 GLY A 339 REMARK 465 ALA A 477 REMARK 465 GLU A 478 REMARK 465 GLU A 479 REMARK 465 GLY A 480 REMARK 465 LYS A 481 REMARK 465 ALA A 482 REMARK 465 GLU A 483 REMARK 465 ILE A 484 REMARK 465 LYS A 485 REMARK 465 SER A 486 REMARK 465 LEU B 328 REMARK 465 ASP B 329 REMARK 465 PRO B 330 REMARK 465 VAL B 331 REMARK 465 TYR B 332 REMARK 465 LEU B 333 REMARK 465 LYS B 334 REMARK 465 HIS B 335 REMARK 465 SER B 336 REMARK 465 HIS B 337 REMARK 465 GLN B 338 REMARK 465 GLY B 339 REMARK 465 ALA B 477 REMARK 465 GLU B 478 REMARK 465 GLU B 479 REMARK 465 GLY B 480 REMARK 465 LYS B 481 REMARK 465 ALA B 482 REMARK 465 GLU B 483 REMARK 465 ILE B 484 REMARK 465 LYS B 485 REMARK 465 SER B 486 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 431 CD - NE - CZ ANGL. DEV. = 9.0 DEGREES REMARK 500 ARG A 431 NE - CZ - NH1 ANGL. DEV. = -6.5 DEGREES REMARK 500 ARG A 431 NE - CZ - NH2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ARG B 431 CD - NE - CZ ANGL. DEV. = 11.1 DEGREES REMARK 500 ARG B 431 NE - CZ - NH1 ANGL. DEV. = 7.7 DEGREES REMARK 500 ARG B 431 NE - CZ - NH2 ANGL. DEV. = -7.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 79 -116.30 49.39 REMARK 500 SER A 108 89.61 159.86 REMARK 500 LYS A 303 -70.75 -104.07 REMARK 500 ASN A 308 138.71 -36.19 REMARK 500 ASP A 310 55.59 111.12 REMARK 500 CYS A 311 89.42 -165.90 REMARK 500 ARG A 355 149.52 -172.61 REMARK 500 LEU A 406 -143.15 -121.27 REMARK 500 TYR B 79 -117.48 50.48 REMARK 500 SER B 108 90.63 160.19 REMARK 500 LYS B 303 -71.31 -105.47 REMARK 500 ASN B 308 137.69 -37.36 REMARK 500 ASP B 310 55.92 111.21 REMARK 500 CYS B 311 89.23 -165.33 REMARK 500 ARG B 355 149.03 -175.60 REMARK 500 LEU B 406 -140.96 -119.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 142 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 142 B 702 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JS6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DOPA DECARBOXYLASE DBREF 1JS3 A 1 486 UNP P80041 DDC_PIG 1 486 DBREF 1JS3 B 1 486 UNP P80041 DDC_PIG 1 486 SEQRES 1 A 486 MET ASN ALA SER ASP PHE ARG ARG ARG GLY LYS GLU MET SEQRES 2 A 486 VAL ASP TYR MET ALA ASP TYR LEU GLU GLY ILE GLU GLY SEQRES 3 A 486 ARG GLN VAL TYR PRO ASP VAL GLN PRO GLY TYR LEU ARG SEQRES 4 A 486 PRO LEU ILE PRO ALA THR ALA PRO GLN GLU PRO ASP THR SEQRES 5 A 486 PHE GLU ASP ILE LEU GLN ASP VAL GLU LYS ILE ILE MET SEQRES 6 A 486 PRO GLY VAL THR HIS TRP HIS SER PRO TYR PHE PHE ALA SEQRES 7 A 486 TYR PHE PRO THR ALA SER SER TYR PRO ALA MET LEU ALA SEQRES 8 A 486 ASP MET LEU CYS GLY ALA ILE GLY CYS ILE GLY PHE SER SEQRES 9 A 486 TRP ALA ALA SER PRO ALA CYS THR GLU LEU GLU THR VAL SEQRES 10 A 486 MET MET ASP TRP LEU GLY LYS MET LEU GLN LEU PRO GLU SEQRES 11 A 486 ALA PHE LEU ALA GLY GLU ALA GLY GLU GLY GLY GLY VAL SEQRES 12 A 486 ILE GLN GLY SER ALA SER GLU ALA THR LEU VAL ALA LEU SEQRES 13 A 486 LEU ALA ALA ARG THR LYS VAL VAL ARG ARG LEU GLN ALA SEQRES 14 A 486 ALA SER PRO GLY LEU THR GLN GLY ALA VAL LEU GLU LYS SEQRES 15 A 486 LEU VAL ALA TYR ALA SER ASP GLN ALA HIS SER SER VAL SEQRES 16 A 486 GLU ARG ALA GLY LEU ILE GLY GLY VAL LYS LEU LYS ALA SEQRES 17 A 486 ILE PRO SER ASP GLY LYS PHE ALA MET ARG ALA SER ALA SEQRES 18 A 486 LEU GLN GLU ALA LEU GLU ARG ASP LYS ALA ALA GLY LEU SEQRES 19 A 486 ILE PRO PHE PHE VAL VAL ALA THR LEU GLY THR THR SER SEQRES 20 A 486 CYS CYS SER PHE ASP ASN LEU LEU GLU VAL GLY PRO ILE SEQRES 21 A 486 CYS HIS GLU GLU ASP ILE TRP LEU HIS VAL ASP ALA ALA SEQRES 22 A 486 TYR ALA GLY SER ALA PHE ILE CYS PRO GLU PHE ARG HIS SEQRES 23 A 486 LEU LEU ASN GLY VAL GLU PHE ALA ASP SER PHE ASN PHE SEQRES 24 A 486 ASN PRO HIS LYS TRP LEU LEU VAL ASN PHE ASP CYS SER SEQRES 25 A 486 ALA MET TRP VAL LYS ARG ARG THR ASP LEU THR GLY ALA SEQRES 26 A 486 PHE LYS LEU ASP PRO VAL TYR LEU LYS HIS SER HIS GLN SEQRES 27 A 486 GLY SER GLY LEU ILE THR ASP TYR ARG HIS TRP GLN LEU SEQRES 28 A 486 PRO LEU GLY ARG ARG PHE ARG SER LEU LYS MET TRP PHE SEQRES 29 A 486 VAL PHE ARG MET TYR GLY VAL LYS GLY LEU GLN ALA TYR SEQRES 30 A 486 ILE ARG LYS HIS VAL GLN LEU SER HIS GLU PHE GLU ALA SEQRES 31 A 486 PHE VAL LEU GLN ASP PRO ARG PHE GLU VAL CYS ALA GLU SEQRES 32 A 486 VAL THR LEU GLY LEU VAL CYS PHE ARG LEU LYS GLY SER SEQRES 33 A 486 ASP GLY LEU ASN GLU ALA LEU LEU GLU ARG ILE ASN SER SEQRES 34 A 486 ALA ARG LYS ILE HIS LEU VAL PRO CYS ARG LEU ARG GLY SEQRES 35 A 486 GLN PHE VAL LEU ARG PHE ALA ILE CYS SER ARG LYS VAL SEQRES 36 A 486 GLU SER GLY HIS VAL ARG LEU ALA TRP GLU HIS ILE ARG SEQRES 37 A 486 GLY LEU ALA ALA GLU LEU LEU ALA ALA GLU GLU GLY LYS SEQRES 38 A 486 ALA GLU ILE LYS SER SEQRES 1 B 486 MET ASN ALA SER ASP PHE ARG ARG ARG GLY LYS GLU MET SEQRES 2 B 486 VAL ASP TYR MET ALA ASP TYR LEU GLU GLY ILE GLU GLY SEQRES 3 B 486 ARG GLN VAL TYR PRO ASP VAL GLN PRO GLY TYR LEU ARG SEQRES 4 B 486 PRO LEU ILE PRO ALA THR ALA PRO GLN GLU PRO ASP THR SEQRES 5 B 486 PHE GLU ASP ILE LEU GLN ASP VAL GLU LYS ILE ILE MET SEQRES 6 B 486 PRO GLY VAL THR HIS TRP HIS SER PRO TYR PHE PHE ALA SEQRES 7 B 486 TYR PHE PRO THR ALA SER SER TYR PRO ALA MET LEU ALA SEQRES 8 B 486 ASP MET LEU CYS GLY ALA ILE GLY CYS ILE GLY PHE SER SEQRES 9 B 486 TRP ALA ALA SER PRO ALA CYS THR GLU LEU GLU THR VAL SEQRES 10 B 486 MET MET ASP TRP LEU GLY LYS MET LEU GLN LEU PRO GLU SEQRES 11 B 486 ALA PHE LEU ALA GLY GLU ALA GLY GLU GLY GLY GLY VAL SEQRES 12 B 486 ILE GLN GLY SER ALA SER GLU ALA THR LEU VAL ALA LEU SEQRES 13 B 486 LEU ALA ALA ARG THR LYS VAL VAL ARG ARG LEU GLN ALA SEQRES 14 B 486 ALA SER PRO GLY LEU THR GLN GLY ALA VAL LEU GLU LYS SEQRES 15 B 486 LEU VAL ALA TYR ALA SER ASP GLN ALA HIS SER SER VAL SEQRES 16 B 486 GLU ARG ALA GLY LEU ILE GLY GLY VAL LYS LEU LYS ALA SEQRES 17 B 486 ILE PRO SER ASP GLY LYS PHE ALA MET ARG ALA SER ALA SEQRES 18 B 486 LEU GLN GLU ALA LEU GLU ARG ASP LYS ALA ALA GLY LEU SEQRES 19 B 486 ILE PRO PHE PHE VAL VAL ALA THR LEU GLY THR THR SER SEQRES 20 B 486 CYS CYS SER PHE ASP ASN LEU LEU GLU VAL GLY PRO ILE SEQRES 21 B 486 CYS HIS GLU GLU ASP ILE TRP LEU HIS VAL ASP ALA ALA SEQRES 22 B 486 TYR ALA GLY SER ALA PHE ILE CYS PRO GLU PHE ARG HIS SEQRES 23 B 486 LEU LEU ASN GLY VAL GLU PHE ALA ASP SER PHE ASN PHE SEQRES 24 B 486 ASN PRO HIS LYS TRP LEU LEU VAL ASN PHE ASP CYS SER SEQRES 25 B 486 ALA MET TRP VAL LYS ARG ARG THR ASP LEU THR GLY ALA SEQRES 26 B 486 PHE LYS LEU ASP PRO VAL TYR LEU LYS HIS SER HIS GLN SEQRES 27 B 486 GLY SER GLY LEU ILE THR ASP TYR ARG HIS TRP GLN LEU SEQRES 28 B 486 PRO LEU GLY ARG ARG PHE ARG SER LEU LYS MET TRP PHE SEQRES 29 B 486 VAL PHE ARG MET TYR GLY VAL LYS GLY LEU GLN ALA TYR SEQRES 30 B 486 ILE ARG LYS HIS VAL GLN LEU SER HIS GLU PHE GLU ALA SEQRES 31 B 486 PHE VAL LEU GLN ASP PRO ARG PHE GLU VAL CYS ALA GLU SEQRES 32 B 486 VAL THR LEU GLY LEU VAL CYS PHE ARG LEU LYS GLY SER SEQRES 33 B 486 ASP GLY LEU ASN GLU ALA LEU LEU GLU ARG ILE ASN SER SEQRES 34 B 486 ALA ARG LYS ILE HIS LEU VAL PRO CYS ARG LEU ARG GLY SEQRES 35 B 486 GLN PHE VAL LEU ARG PHE ALA ILE CYS SER ARG LYS VAL SEQRES 36 B 486 GLU SER GLY HIS VAL ARG LEU ALA TRP GLU HIS ILE ARG SEQRES 37 B 486 GLY LEU ALA ALA GLU LEU LEU ALA ALA GLU GLU GLY LYS SEQRES 38 B 486 ALA GLU ILE LYS SER HET SO4 A 802 5 HET SO4 A 803 5 HET PLP A 601 15 HET 142 A 701 16 HET SO4 B 801 5 HET SO4 B 804 5 HET PLP B 602 15 HET 142 B 702 16 HETNAM SO4 SULFATE ION HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM 142 CARBIDOPA HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN 142 KINSON; 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL- HETSYN 2 142 PROPIONIC ACID FORMUL 3 SO4 4(O4 S 2-) FORMUL 5 PLP 2(C8 H10 N O6 P) FORMUL 6 142 2(C10 H14 N2 O4) FORMUL 11 HOH *455(H2 O) HELIX 1 1 ASN A 2 GLY A 23 1 22 HELIX 2 2 ILE A 24 ARG A 27 5 4 HELIX 3 3 LEU A 38 ILE A 42 5 5 HELIX 4 4 THR A 52 ILE A 63 1 12 HELIX 5 5 ILE A 64 VAL A 68 5 5 HELIX 6 6 SER A 85 GLY A 99 1 15 HELIX 7 7 SER A 104 ALA A 107 5 4 HELIX 8 8 SER A 108 LEU A 126 1 19 HELIX 9 9 PRO A 129 LEU A 133 5 5 HELIX 10 10 SER A 147 SER A 171 1 25 HELIX 11 11 THR A 175 LYS A 182 1 8 HELIX 12 12 HIS A 192 GLY A 203 1 12 HELIX 13 13 ARG A 218 ALA A 232 1 15 HELIX 14 14 ASN A 253 GLU A 264 1 12 HELIX 15 15 TYR A 274 CYS A 281 5 8 HELIX 16 16 PHE A 284 ASN A 289 5 6 HELIX 17 17 GLY A 290 ALA A 294 5 5 HELIX 18 18 ASN A 300 LEU A 305 1 6 HELIX 19 19 ARG A 318 GLY A 324 1 7 HELIX 20 20 ALA A 325 LYS A 327 5 3 HELIX 21 21 ASP A 345 TRP A 349 5 5 HELIX 22 22 ARG A 358 ASP A 395 1 38 HELIX 23 23 SER A 416 ARG A 431 1 16 HELIX 24 24 GLU A 456 ALA A 476 1 21 HELIX 25 25 ASN B 2 GLY B 23 1 22 HELIX 26 26 ILE B 24 ARG B 27 5 4 HELIX 27 27 LEU B 38 ILE B 42 5 5 HELIX 28 28 THR B 52 ILE B 63 1 12 HELIX 29 29 ILE B 64 VAL B 68 5 5 HELIX 30 30 SER B 85 GLY B 99 1 15 HELIX 31 31 SER B 104 ALA B 107 5 4 HELIX 32 32 SER B 108 LEU B 126 1 19 HELIX 33 33 PRO B 129 LEU B 133 5 5 HELIX 34 34 SER B 147 SER B 171 1 25 HELIX 35 35 THR B 175 LYS B 182 1 8 HELIX 36 36 HIS B 192 GLY B 203 1 12 HELIX 37 37 ARG B 218 ALA B 232 1 15 HELIX 38 38 ASN B 253 GLU B 264 1 12 HELIX 39 39 TYR B 274 CYS B 281 5 8 HELIX 40 40 PHE B 284 ASN B 289 5 6 HELIX 41 41 GLY B 290 ALA B 294 5 5 HELIX 42 42 ASN B 300 LEU B 305 1 6 HELIX 43 43 ARG B 318 GLY B 324 1 7 HELIX 44 44 ALA B 325 LYS B 327 5 3 HELIX 45 45 ASP B 345 TRP B 349 5 5 HELIX 46 46 ARG B 358 ASP B 395 1 38 HELIX 47 47 SER B 416 ARG B 431 1 16 HELIX 48 48 GLU B 456 ALA B 476 1 21 SHEET 1 A 7 GLY A 141 GLN A 145 0 SHEET 2 A 7 SER A 312 VAL A 316 -1 O SER A 312 N GLN A 145 SHEET 3 A 7 SER A 296 PHE A 299 -1 N PHE A 299 O ALA A 313 SHEET 4 A 7 TRP A 267 ASP A 271 1 N VAL A 270 O SER A 296 SHEET 5 A 7 ILE A 235 THR A 242 1 N ALA A 241 O ASP A 271 SHEET 6 A 7 LEU A 183 SER A 188 1 N TYR A 186 O PHE A 238 SHEET 7 A 7 LYS A 205 ILE A 209 1 O LYS A 205 N ALA A 185 SHEET 1 B 4 PHE A 398 VAL A 400 0 SHEET 2 B 4 LEU A 408 LEU A 413 -1 O ARG A 412 N GLU A 399 SHEET 3 B 4 GLN A 443 ALA A 449 -1 O LEU A 446 N PHE A 411 SHEET 4 B 4 VAL A 436 LEU A 440 -1 N CYS A 438 O VAL A 445 SHEET 1 C 7 GLY B 141 GLN B 145 0 SHEET 2 C 7 SER B 312 VAL B 316 -1 O SER B 312 N GLN B 145 SHEET 3 C 7 SER B 296 PHE B 299 -1 N PHE B 299 O ALA B 313 SHEET 4 C 7 TRP B 267 ASP B 271 1 N VAL B 270 O SER B 296 SHEET 5 C 7 ILE B 235 THR B 242 1 N ALA B 241 O ASP B 271 SHEET 6 C 7 LEU B 183 SER B 188 1 N TYR B 186 O PHE B 238 SHEET 7 C 7 LYS B 205 ILE B 209 1 O LYS B 205 N ALA B 185 SHEET 1 D 4 PHE B 398 VAL B 400 0 SHEET 2 D 4 LEU B 408 LEU B 413 -1 O ARG B 412 N GLU B 399 SHEET 3 D 4 GLN B 443 ALA B 449 -1 O LEU B 446 N PHE B 411 SHEET 4 D 4 VAL B 436 LEU B 440 -1 N CYS B 438 O VAL B 445 LINK C4A PLP A 601 N 142 A 701 1555 1555 1.34 LINK C4A PLP B 602 N 142 B 702 1555 1555 1.34 SITE 1 AC1 5 ASN A 2 ALA A 3 TYR B 86 ARG B 453 SITE 2 AC1 5 LYS B 454 SITE 1 AC2 5 TYR A 86 ARG A 453 LYS A 454 ASN B 2 SITE 2 AC2 5 ALA B 3 SITE 1 AC3 3 ARG A 347 HIS A 348 HOH B 941 SITE 1 AC4 2 ARG B 347 HIS B 348 SITE 1 AC5 14 SER A 147 ALA A 148 SER A 149 HIS A 192 SITE 2 AC5 14 SER A 194 THR A 246 ASP A 271 ALA A 273 SITE 3 AC5 14 ASN A 300 HIS A 302 LYS A 303 142 A 701 SITE 4 AC5 14 HOH A 805 HOH A 908 SITE 1 AC6 14 SER B 147 ALA B 148 SER B 149 HIS B 192 SITE 2 AC6 14 SER B 194 THR B 246 ASP B 271 ALA B 273 SITE 3 AC6 14 ASN B 300 HIS B 302 LYS B 303 142 B 702 SITE 4 AC6 14 HOH B 959 HOH B 987 SITE 1 AC7 10 TYR A 79 PHE A 80 PRO A 81 THR A 82 SITE 2 AC7 10 HIS A 192 HIS A 302 LYS A 303 PLP A 601 SITE 3 AC7 10 HOH A1001 HOH A1003 SITE 1 AC8 10 TYR B 79 PHE B 80 PRO B 81 THR B 82 SITE 2 AC8 10 HIS B 192 THR B 246 HIS B 302 LYS B 303 SITE 3 AC8 10 PLP B 602 HOH B1022 CRYST1 154.360 154.360 86.780 90.00 90.00 120.00 P 62 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006478 0.003740 0.000000 0.00000 SCALE2 0.000000 0.007481 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011523 0.00000